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Materials and Methods
Fatty acid transport and binding
Cells were grown to mid-log phase (5 X 108 cells/ml) in minimal medium containing 5
mM potassium acetate and ampicillin as required, after which arabinose (0.05%) was
added for 1 hr. The cells were harvested by centrifugation, resuspended in 0.5 volume
medium E containing 200 µg/ml chloramphenicol, and starved for any carbon and energy
source for 30 min at 30•C.  LCFA transport was carried out as described by Kumar and
Black (25).  Fatty acid transport experiments were done at least six times, in duplicate.
LCFA binding experiments were carried out essentially as described by Black (23).  One
volume of starved cells was added to a reaction cocktail resulting in oleate:bovine serum
albumin (BSA) ratios of 2.0, 1.0, and 0.5.  The BSA concentrations were held constant at
173µM and the oleate (specific activity = 23 Ci/mmol) concentrations varied accordingly.
All fatty acid binding experiments were done at least four times, in duplicate. For strain
references see (30 (LS1548), S1 (LS6164), 14 (LS6949)).
Protein preparation
The gene for Escherichia coli FadL including the signal sequence was amplified from
genomic DNA by PCR, digested with EcoRI/XbaI, and ligated with the EcoRI/XbaI
digested pBAD22 vector (S2), which is under the control of the arabinose promotor. A
hexa-histidine tag was attached at the C-terminus of FadL in order to facilitate
purification. The protein was expressed in E.coli C43 (DE3) cells at 37 °C by induction
with 0.2% arabinose for 3-4 hrs. The following steps were all done on ice; the procedure
describes how the monoclinic crystal form was obtained. After harvesting by
centrifugation, the cells were lysed in 20mM Tris-HCl/300 mM NaCl/10% glycerol pH
7.8 (TSG buffer) using a microfluidizer (Microfluidics). Total membranes were collected
by centrifugation at 40,000 rpm for 40 min and solubilized by homogenization in 1%
LDAO/1% OG (w/v) in TSG buffer followed by stirring for 45 min. After centrifugation
for 30 min at 40,000 rpm the supernatant was loaded onto a ~15 ml Nickel column
(metal-chelating Sepharose, Pharmacia Biotech). The column was washed with 10
volumes of TSB with 0.2% LDAO in the presence of 10 mM imidazole. His-tagged FadL
was eluted with 250 mM imidazole, concentrated to ~10 ml, and loaded onto a Superdex-
200 26/60 gel filtration column equilibrated with 10 mM sodium acetate/50 mM
NaCl/10% glycerol/0.05% LDAO pH 5.6. The gel filtration step was followed by ion
exchange on a Mono-S 10/10 column equilibrated in 10 mM sodium acetate/50 mM
NaCl/10% glycerol/0.45% C8E4 pH 5.6. FadL eluted in 2 broad peaks, at ~ 50 mM NaCl
(flowthrough) and at ~150 mM NaCl. Only the protein in the flowthrough fraction gave
well-diffracting monoclinic crystals. If the LDAO was exchanged thoroughly by washing
the column extensively with C8E4 buffer, no well-diffracting crystals were obtained. The
protein that yielded the hexagonal crystal form was purified in an identical way, with the
final ion exchange step performed at pH 4.9, where the protein eluted as a broad peak
between 0.1 and 0.4 M NaCl. Seleno-methionine substituted protein was expressed in
wild-type C43 cells by inhibition of the methionine biosynthesis pathway (S3). Cells
were grown in minimal M9 medium supplemented with 0.2% glucose and 5% (v/v)
glycerol as carbon sources, and induced with 1% arabinose for 8 hrs. Purification was as
described for the native protein, with 0.5 mM Tris-(2-carboxyethyl)phosphine added to
buffers to avoid oxidation.
Although the aromatic character of the C-terminal residue of OM proteins is
important for stability and integration into the OM (S4), the presence of the C-terminal
hexameric histidine tag had no effect on the localization or function of FadL. The
purified protein was properly folded as indicated by its lower mobility in SDS-gels
following heat treatment (data not shown). To test whether the histidine tag affected the
function of FadL, the protein was expressed from a plasmid in an E. coli strain lacking
endogenous FadL, and binding of oleic acid to the cells was determined in strains lacking
the downstream enzyme FadD (Table S1). While binding in the absence of FadL was
very low (strain LS6949), the histidine-tagged FadL protein allowed binding of oleic acid
at the same level as the non-tagged protein. The level of binding was slightly higher than
in a control strain containing endogenous FadL (LS1908). Transport assays performed in
strains containing FadD also showed that the level of oleic acid uptake was similar to that
in a control strain (LS1548) and much higher than in a strain lacking FadL (LS6164).
Thus, the histidine-tagged protein appears to be fully functional.  In addition, like the
wild-type protein, it functioned as a receptor for bacteriophage T2 (data not shown).
Crystallization
A number of initial crystallization conditions for FadL were found with hanging drop
vapor diffusion using a broad screen at 4 °C and 22 °C with protein purified in LDAO, β-
OG and C8E4. After optimization, the best monoclinic crystals were obtained at 22 °C in
27-32% PEG 4K/50 mM cacodylate/2-5 mM CuSO4 pH 5.3, by mixing 2 µl of an 8
mg/ml protein solution with 1 µl well solution at 22 °C. Bar-shaped crystals appeared
overnight and grew to maximum dimensions of 100 x 250 x 700 µM in 4-5 days. They
belong to spacegroup P21, diffract to 2.6 Å, and have 2 molecules in the asymmetric unit
(Vm = 3.9 Å3/Da, corresponding to a solvent content of ~59%). Selenomethionine-
substituted crystals were obtained under similar conditions (with PEG5K MME instead
of PEG4K), but did not diffract beyond 6 Å. The hexagonal crystals were obtained from
Crystal Screen I (Hampton research), condition 44 (0.2 M magnesium formate pH 6.8).
They appeared after 3-4 days and grew to 300 x 300 x 100 µM in a week. They diffract to
2.8 Å and have 2 molecules in the asymmetric unit (Vm = 3.8 Å3/Da, solvent content
~68%). For heavy atom derivatization, small volumes of heavy atoms solutions in mother
liquor were added to the crystallization drop to final concentrations between 0.5 and 5
mM. Soak times varied between 2 and 18 hrs. For cryoprotection of the monoclinic
crystals, the glycerol concentration in the drop was gradually increased to ~17% by direct
addition to the drop of mother liquor with 20% glycerol and 0.45% C8E4. The hexagonal
crystals were cryoprotected by direct transfer into mother liquor with 0.3% C8E4 and 50%
glycerol. Crystals were flash-frozen in liquid nitrogen.
Attempts to soak LCFAs into the FadL crystals were not successful, as was co-
crystallization of FadL in the presence of fatty acids. There may be several reasons for
this; first of all, due to the presence of both E319 and R157 as ligands for the zwitterionic
LDAO molecule, its affinity for the P1 binding site could be similar or even higher than
that of an LCFA, despite the relatively short length of the LDAO alkyl chain. In addition,
since the LCFAs partition into the detergent micelles and change their properties, it was
not possible to use fatty acid concentrations higher than 0.5-1 mM in the soak and co-
crystallization experiments, which might have been too low to displace the LDAO
molecule. It also appears that it may be difficult to obtain good crystals without a bound
ligand (LDAO or fatty acids) in the high affinity site P1; only poor-quality crystals could
be obtained from an LDAO-free preparation (i.e. by extensively exchanging LDAO for
C8E4).
Data collection, structure determination and refinement
Diffraction data were collected at 100K on beamlines at either the National Synchrotron
Light Source (NSLS) at Brookhaven National Labs (X25) or at the Advanced Photon
Source at Argonne National Labs (8-BM) (Table S2). Data were indexed and scaled with
HKL2000 (S5). For the monoclinic crystals, MIR and SAD datasets were recorded from
YbCl3 and K2PtCl4 soaked crystals at the Yb and Pt peak wavelengths. Initial heavy atom
positions were obtained with SOLVE (S6) and refined using SHARP (S7). After density
modification (using DM) with 2-fold NCS averaging, phase extension and solvent
flattening, electron density maps were obtained that allowed an initial model to be built
with O (S8). Iterative cycles of torsion angle refinement and B-factor refinement in CNS
(S9) followed by model building in O resulted in a final model with an Rfree of 30.2%,
including all residues (1-421) of the protein and the C-terminal hexa-histidine tag. During
the later stages of refinement the NCS restraints were relaxed from an initial value of 300
to 10. Phases for the hexagonal crystal form were obtained using MIR datasets recorded
for OsCl3, uranyl-acetate and K2PtCl4 soaked crystals. The refined monoclinic FadL
model was placed manually into the experimental electron density maps of the hexagonal
crystal form, followed by rigid-body refinement, torsion angle refinement with NCS
restraints and B-factor refinement in CNS, followed by model building in O. The final
model includes all residues of the protein (Rfree 33.1%; in this case no density is observed
for the histidine tag. For refinement statistics see Table S2.
Supplementary Figures
Fig. S1 ClustalW sequence alignment of FadL homologues. Sequences from the following
organisms were selected for alignment (with their SWISS-PROT accession numbers): P10384;
FadL, Escherichia coli, Q8ZNA5; FadL, Salmonella typhimurium, Q8ZD48; FadL, Yersinia
pestis, Q9K2Q4; FadL, Haemophilis influenzae, Q9K1M2; FadL, Neisseria menigitidis,
Q8VMI2; toluene transporter XylN from Pseudomonas putida. Selected amino acid residues
mentioned in the text are shown in colors: the conserved NPA sequence of the hatch in red,
glycine residues in green, charged residues in blue, and hydrophobic residues within 4 Å of the
high-affinity binding site (Fig. 2B) in gray. The symbols underneath the alignment indicate the
degree of conservation: identical residues are shown as “*”, highly similar residues are shown as
“:”, and similar residues are shown as “.”.
                        1        10        20        30        40         50
P10384|FADL_ECOLI          AGFQLNEFSSSGLGRAYSGEGAIADDAGNVSRNPALITMFDRP-TFSAGAVYIDPDVNI
Q8ZNA5|FADL_SALTY          AGFQLNEFSSSGLGRAYSGEGAIADDAGNVSRNPALITMFDRP-TFSAGAVYIDPDVNI
Q8ZD48|FADL_YERSP          AGFQLNEYSAAALGRAFSGEGAVADNASVGSRNPAAMTLFDRP-SFSGGVIYIDPSVDI
Q9K2Q4|FADL_HAEMI          AAFQLAEVSTSGLGRAYAGEAAIADNASVVATNPALMSLFKTA-QFSTGGVYVDSRINM
Q9K1M2|FADL_NEISM          SGYHFGTQSVNAQSTANAAAAEAAD-ASTIFYNPAGLTKLDSS-QISVNANIVLPSIHY
Q8VMI2|XYLN_PSEUP          DGLFLEGFGAISRSMGGTAVAHYVG-PASMMVNPATMDLSDSAGELLLGFDLITTDIGA
                                   .  . . . :. .  .. ..    *** :   . .  :  .   : . :
                                  60                   70        80        90        100
P10384                    SG------TSPSGRSLK-----ADNIAPTAWVPNMHFVAPINDQFGWGASITSNYGLATE
Q8ZNA5                    SG------TSPSRRTLD-----ADNIAPTAWVPNVHFVAPINDQFGWGASITSNYGLATE
Q8ZD48                    TG------TSPSGKSTD-----ASNIAPSAWVPNLHFIMPLDEQWAIGASATSNYGLATE
Q9K2Q4                    NGDVDSSITATTMRTTKYGSASARNVIPGAFVPNLYFVAPVNDKFALGAGMNVNFGLKSK
Q9K1M2                    EADSATDFTGLPVQGSK-----SGKITKTTVAPHIYGAYKVNDNLTVGLGVYVPFGSATE
Q8VMI2                    TN----PETGQHVSSSD-----HSNNRGPYVAPQFAYIHKVSN-WTFGAGVFAQAGVGVE
                                  *.      .       :      .*:.     :.:    * .     *   :
                            110                      120       130       140       150
P10384                    FNDT--YAGGSVGG-------------TTDLETMNLNLSGAYRLNNAWSFGLGFNAVYAR
Q8ZNA5                    FNDT--YAGGSVGG-------------TTDLETMNLNLSGAYRLNEAWSFGLGFDAVYAR
Q8ZD48                    FNDD--YVAGMLGG-------------QTDLKTANLNLSAAYRLNDNFSFGLGFDAVYAD
Q9K2Q4                    YDDS--YDAGVFGG-------------KTDLTAINLNLSGAYRVTEGLSLGLGVNAVYAK
Q9K1M2                    YEKD--SVLRHNIN-------------KLGLTSIAVEPVAAWKLNDRHSFGAGIIAQHTS
Q8VMI2                    YGNDSFLSRGDVGGKGYAAGADTGLENASRLFILDIPFAASFKVNDRLAIGGSLDAKWTG
                          : .          .                *    :   .::::.:  ::* .. *  :
                                 160        170       180       190       200        210
P10384                    AKIERFAGDLGQ-LVAGQIMQSPAGQTQQGQALAATANGIDSNTKIAHLNG-NQWGFGWN
Q8ZNA5                    AKIERFAGDLGQ-LVA-----------AQNPALAPVAGQIPSDTKIAHLNG-NQWGFGWN
Q8ZD48                    AKIVRHLGEAG----------------------G---GLLPANTEAARLEG-TKWGYGWN
Q9K2Q4                    AQVERNAGIIAE-SVKIAQN----AIKTVNPKDKATDYLTSKDKSVVSLQDRAAWGFGWN
Q9K1M2                    AELRKYADWGIK-SKAEILT-----AKPPKPNGVAEAAKIQADG-HADVKG-SDWGFGYQ
Q8VMI2                    LNLDYLLGMNQLGSLAGDGRASGSLMGVIGTLPDPRGVHLSVSKNKEMSSGVDGWGYSAR
                           ::    .                                  .      ..   **:. .
                                   220       230         240       250       260
P10384                    AGILYELDKNNRYALTYRSEVKI-DFKGN-YSSDLNRAFNNYGLPIPTATGGATQ--SGY
Q8ZNA5                    AGILYELDKNNRYALTYRSEVKI-DFKGN-YSSDLPIAINRFNLPIPTATGGATQ--SGY
Q8ZD48                    TGILYEIDKENRYSFTYRSEVNI-DFDGD-YSNQLPVIFG--------GLGGKTV--PGS
Q9K2Q4                    AGVMYQFNEANRIGLAYHSKVDI-DFTDR-TATSLEAEVI---------EAGK----KGN
Q9K1M2                    LAWMWDINDRARVGVNYRSKVSH-TLKGD-AEWAADGAAAKAMWSTMLAANGYTANEKAR
Q8VMI2                    LGLLYKVAPTTNVGVSYMFKSHMNDLKGKGTVTAVDGIAGN------VPIEGEVR----F
                           . ::..    . .. *  :     : .                       *
                             270       280       290        300       310       320
P10384                    LTLNLPEMWEVSGYNRVDPQWAIHYSLAYTSWS-QFQQLKATSTSGDTLFQKHEG-----
Q8ZNA5                    LTLNLPEMWEVSGYNRVAPQWAIHYSLAYTSWS-QFQELKAKSTAGDTLFEKHEG-----
Q8ZD48                    LTLNLPAVWEVSGYNKVAPQWAIHYSMAYTTWS-SFKELKATASNGDVLFDKHEG-----
Q9K2Q4                    LTLTLPDYLELSGFHQLTDKFAVHYSYKYTHWS-RLTKLHASFEDGKKAFDKELQ-----
Q9K1M2                    VKIVTPESLSVHGMYKVSDKADLFGDVTWTRHS-RFDKAELVFEKEKTVVKGKSDRTTIT
Q8VMI2                    LDFNTPAKLDVGISHQVTDKWLIAFDVSRVFWKDALKDIKLGFASGMGDVDLKLP-----
                          : :  *   .:    ::  :  :  .   .  .  : . .         .. .
                                     330       340       350        360       370
P10384                    --FKDAYRIALGTTYYYDDNWTFRTGIAFDDSPVP-AQNRSISIPDQDRFWLSAGTTYAF
Q8ZNA5                    --FKDAYRIALGTTYYYDDNWTFRTGIAFDDSPVP-AQNRSISIPDQDRFWLSAGTTYAF
Q8ZD48                    --FRDAYRIALGTTYYYDDNWTFRTGIAFDDSPIP-AGNRSISIPDQDRFWLSAGTTYAF
Q9K2Q4                    --YSNNSRVALGASYNLDEKLTLRAGIAYDQAAS--RHHRSAAIPDTDRTWYSLGATYKF
Q9K1M2                    PNWRNTYKVGFGGSYQISEPLQLRAGIAFDKSPVRNADYRMNSLPDGNRIWFSAGMKYHI
Q8VMI2                    QDAKDQTIMAIGTSYSVTPRLTLRAGYRHATQPFN-DEGLLALIPAVLQDHASLGFSYQL
                              :   :.:* :*       :*:*  .   .          :*   :   * * .* :
                            380       390          400               410        421
P10384                    NKDASVDVGVSYMHGQSVKINE---GP--------YQFESEGKAWLFGTNFNYAF-
Q8ZNA5                    NKDASVDVGVSYMHGQSVKINE---GP--------YQFESEGKAWLFGTNFNYAF-
Q8ZD48                    NKNASVDVGIAYMKGQNVSITEKTPAPS----NTTYEFNSKGSAMLYGVNFNYTF-
Q9K2Q4                    TPNLSVDLGYAYLKGKKVHFKEVQKAVGGF-ITTTANYTSQAHANLYGLNLNYSF-
Q9K1M2                    GKNHVVDAAYTHIHINDTSYRTAKASGNDVDSKGASSARFKNHADIIGLQYTYKFK
Q8VMI2                    SKSGRFDAAYSHAFKESMTNRSAYNTS--------SPVKSSIAQDNFVLAYNYSF-
                            .  .* . ::   :.                       .          .* *
Fig. S2 Structural changes in the N-terminus of FadL. Stereoviews of experimental (2Fo-
Fc) density, contoured at 1σ, of the N-terminus (residues 1-12) of monoclinic (A) and
hexagonal (B) FadL, shown with their orientations in the full-length protein. In the
models, oxygen atoms are shown in red and nitrogen atoms in blue.
Fig. S3 Ribbon diagrams of a side view (A) and a bottom view (B) of monoclinic FadL
showing the Cα B-factors: blue, B < 50 Å2; green, 50 Å2 • B < 75 Å2; yellow, 75 Å2 • B
< 100 Å2; red, B • 100 Å2. The location of the NPA sequence in the hatch is shown in
(B). The B-factors for the hexagonal crystal form are not shown, since their relative
values are very similar to those in the monoclinic crystal form.
Supplementary Tables
________________________________________________________________________
Table S1 Fatty acid binding and transport by wild type and C-terminally
His-tagged FadL. For details see Materials and Methods
________________________________________________________________________
Fatty acid binding (C18:1)a
________________________________________________________________________
Strain Genotype Binding (pmole/mg)
(+/- SEM)b
LS6949c fadl∆/fadD∆/fadR 89.9(12.4)
LS1908 fadD∆/fadR∆ 417.8(12.7)
LS6949/pB22d fadl∆/fadD∆/fadR/FadL6xHis 723.6(23.9)
LS6949/pN130e fadl∆/fadD∆/fadR/FadL+ 673.6(33.4)
________________________________________________________________________
Fatty acid transport (C18:1)
________________________________________________________________________
Strain Genotype Transport
(pmole/min/mg protein)
(+/- SEM)b
LS6164 fadl∆/fadR 9.4(4.4)
LS1548 fadR∆ 684.5(60.7)
LS6164/pB22 fadl∆/fadR/FadL6xHis 617.3(52.5)
________________________________________________________________________
a
 FFA/BSA ration = 2, with BSA concentration = 173 µM (see Materials and Methods)
b
 SEM: standard error of the mean; n = 6 (transport), n = 4 (binding)
c
 For strain references see materials and Methods
d
 pB22 encodes the C-terminally hexa-histidine tagged FadL (FadL6xHis)
e
 pN130 encodes native FadL (FadL+)
Table S2 Data collection and refinement statistics
Data collection
Monoclinic data set (P21) Native YbCl3 K2PtCl4
________________________________________________________________________
Wavelength (Å) 1.100 1.386 1.072
Resolution (Å) 2.6 3.2 3.4
Completeness (%) 91.1(78.1) 96.8(82.5) 94.5(88.3)
Redundancy 3.3 (3.0) 7.0(5.8) 4.6(3.8)
I/σI 21.5(2.6) 19.5(2.4) 21.2(3.4)
Rsym (%)a 6.9 15.0 9.2
Hexagonal data set (P3121) Native OsCl3 UAc K2PtCl4
________________________________________________________________________
Wavelength (Å) 1.008 1.139 1.008 1.070
Resolution (Å) 2.8 3.0 2.9 2.9
Completeness (%) 98.5(88.5) 98.1(99.0) 99.6(97.7) 90.3(85.3)
Redundancy 7.1 10.9 6.6 4.2
I/σI 22.2(4.4) 31.8(4.4) 28.5(5.5) 18.7(3.1)
Rsym (%) 9.1 9.8 7.6 8.2
________________________________________________________________________
Refinement P21 P3121
________________________________________________________________________
Resolution range (Å) 10.0-2.6 12-2.8
Rwork (%)b, Rfreec 25.7, 30.2 29.5, 33.1
R.m.s.d.
Bond lengths (Å) 0.0083 0.0104
Bond angles (°) 1.39 1.67
Protein atoms 6626 6504
Water molecules 150 106
Detergent molecules
LDAO 4 2
C8E4 3 0
Copper ions 6 0
Ramachandran statistics (%)
Most favored, disallowed 82.1, 0.0 74.6, 0.0
________________________________________________________________________
Values in parentheses are for the highest resolution shell
a
 Rsym = ΣhklΣi|Ii(hkl) – I(hkl)|/ΣhklΣi|Ii(hkl)|, where I(hkl) is the average intensity
b
 Rwork = Σhkl||Fobs| - k|Fcalc||/Σhkl|Fobs|
c Rfree = Rwork for a selected subset (5%) of reflections that was not included in
refinement
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